Question 46

Methylphenidate transdermal patches must be ordered using a DEA Form 222 or the electronic equivalent.

Methylphenidate transdermal patches are classified as Schedule II controlled substances under federal law, which necessitates the use of a DEA Form 222 or its electronic equivalent for ordering.

A) Loperamide tablets

Loperamide tablets are not classified as controlled substances and therefore do not require a DEA Form 222 for ordering. They are available over-the-counter and are not subject to the same regulatory restrictions as controlled medications.

B) Methylphenidate transdermal patches

Methylphenidate transdermal patches are classified as a Schedule II controlled substance, which mandates that they must be ordered using a DEA Form 222 or the electronic equivalent. This regulation is in place due to the potential for abuse and dependence associated with this medication.

C) Butalbital/acetaminophen/caffeine tablets

Butalbital/acetaminophen/caffeine tablets are classified as Schedule III controlled substances. While they are regulated, they do not require a DEA Form 222 for ordering, as that form is specifically for Schedule I and II substances.

D) Guaifenesin/dextromethorphan liquid

Guaifenesin/dextromethorphan liquid is not classified as a controlled substance and is available over-the-counter. As such, it does not require a DEA Form 222 for ordering.

Conclusion

Methylphenidate transdermal patches are the only option listed that must be ordered using a DEA Form 222 or the electronic equivalent, due to their classification as a Schedule II controlled substance. All other options, being either non-controlled or classified as lower schedules, do not require such stringent ordering processes, thereby confirming that B is the correct choice.